Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.
about
The potential of polymeric micelles in the context of glioblastoma therapy.Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of lifePhase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidIntegration of chemotherapy into current treatment strategies for brain metastases from solid tumors.Treatment of Breast Cancer Brain Metastases.Development of a preclinical therapeutic model of human brain metastasis with chemoradiotherapy.A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies.Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.Nanomedicine in cerebral palsy.Temozolomide for treatment of brain metastases: A review of 21 clinical trials.Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells.The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials.Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
P2860
Q27693205-D936176D-119D-4579-98EC-D5D85BCB592AQ33270398-A0C91951-9C9A-4EF2-8D14-29A087368764Q33375710-C5EC827C-FE6A-477B-B20B-8242BC4324B4Q33599167-B5AB9446-8BE0-43E8-8F14-23A00E33E1F6Q34786475-62011AE2-561B-418E-856F-9BC96B5D631CQ34872345-C2409C46-EF40-4394-A814-31857A804089Q36057858-59A18588-8DFC-45E1-8636-7B6E69764B9FQ36820588-3FFE5A42-3B6C-4263-B02D-A4C3F8E09394Q36988072-EF75275A-98A6-4FD7-B20F-1DD5CB05B8FFQ37118928-5A38B2DC-9F00-4722-BF15-7F43F6E29D48Q37281194-56B04594-979C-4694-9CEA-26BBF3B3EE8BQ37576025-5EC89B57-CFA6-49BA-84C3-2FFBDE3377D7Q37870216-4FAD1B24-7773-473D-84A0-CB1EEA902E57Q38822439-263DD420-11FA-4815-B868-E08D0CA8083DQ39242592-5DC65083-CA8D-4619-8841-8497BDCC0CDFQ40182586-7A00102F-4861-4243-B4DB-147A1A368787Q48401767-1C21F288-0279-4772-835F-7B8C4B3C330AQ58579072-1D78FC7F-373A-4E02-B819-2A5822360029
P2860
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase II study of temozolomide ...... metastases from solid tumours.
@ast
Phase II study of temozolomide ...... metastases from solid tumours.
@en
type
label
Phase II study of temozolomide ...... metastases from solid tumours.
@ast
Phase II study of temozolomide ...... metastases from solid tumours.
@en
prefLabel
Phase II study of temozolomide ...... metastases from solid tumours.
@ast
Phase II study of temozolomide ...... metastases from solid tumours.
@en
P2093
P1476
Phase II study of temozolomide ...... metastases from solid tumours.
@en
P2093
Alberto Abbruzzese
Francesco Grillone
Giovannella Palmieri
Liliana Montella
Monica Marra
Pierosandro Tagliaferri
Raffaele Addeo
Raffaele Costanzo
Salvatore Del Prete
Salvatore Venuta
P2860
P2888
P356
10.1007/S00280-005-0001-Z
P577
2005-11-05T00:00:00Z
P5875
P6179
1024162659